2,3-Butanediol (2,3-BD) is a major metabolite produced by Klebsiella pneumoniae KCTC2242, which is a important chemical with wide applications. Three genes important for 2,3-BD biosynthesis acetolactate decarboxylase (budA), acetolactate synthase (budB), and alcohol dehydrogenase (budC) were identified in K. pneumoniae genomic DNA. With the goal of enhancing 2,3-BD production, these genes were cloned into pUC18K expression vectors containing the lacZ promoter and the kanamycin resistance gene to generate plasmids pSB1-7. The plasmids were then introduced into K. pneumoniae using electroporation. All strains were incubated in flask experiments and 2,3-BD production was increased by 60% in recombinant bacteria harboring pSB04 (budA and budB genes), compared with the parental strain K. pneumoniae KCTC2242. The maximum 2,3-BD production level achieved through fedbatch fermentation with K. pneumoniae SGJSB04 was 101.53 g/l over 40 h with a productivity of 2.54 g/l.h. These results suggest that overexpression of 2,3-BD synthesisrelated genes can enhance 2,3-BD production in K. pneumoniae by fermentation.
The bulk chemical 2,3-butanediol (2,3-BD) has extensive industrial applications for which various efficient and economical microbial 2,3-BD production strategies, including strain improvement, are being studied [12] . The conversion of 2,3-BD into methyl ethyl ketone by dehydration indicates that 2,3-BD can be used as a liquid fuel additive. In addition, 2,3-BD can be converted into 1,3-butadiene, a compound used for synthetic rubber production [2, 6] . The biological production of 2,3-BD is mediated by metabolic pathways, and microbial-derived 2,3-BD can be obtained from several microorganisms, such as Aerobacter aerogenes, Klebsiella pneumoniae, and Bacillus polymyxa. These bacteria produce 2,3-BD from glucose metabolized through mixed acid fermentation [11] . The by-products from the fermentation process contain acetoin, ethanol, and lactic and acetic acids [3] . Among these microorganisms, K. pneumoniae has demonstrated the greatest potential for industrial 2,3-BD production, owing to its versatility across substrates and its cultural adaptability [9] . In previous studies, in order to increase production of 2,3-BD, one of the Klebsiella sp. mutants isolated after mutation with UV produced more 2,3-BD than the wild-type strain with decreasing lactic and acetic acids [7] . Mutants of Klebsiella sp. recombinant strains were also constructed by knocking out the aldH gene coding for aldehyde dehydrogenase, which is involved in ethanol production, in order to increase production of 2,3-BD [13] . Therefore, it is important to increase 2,3-BD production by improving strains and decreasing by-products in the fermentation. In addition, the production of 2,3-BD is also effected by pH, oxygen conditions, and NAD/NADH conversion [4, 10] . Our goal is to generate improved Klebsiella strains with increased 2,3-BD production and decreased fermentation by-products.
K. pneumoniae has genes for acetolactate synthase (budB), alpha-acetolactate decarboxylase (budA), and acetoin reductase (budC), which all catalyze the synthesis of 2,3-BD [1, 8] . These genes are known the as budABC operon, which regulates the 2,3-BD production [1, 8] . However, the impact on 2,3-BD production of each gene has not been shown. Therefore, to compare the effect of each gene and enhance 2,3-BD production, the overexpression of all the genes (budB, budA, and budC) in various combinations was attempted.
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In this study, we report high production of 2,3-BD from glucose by overexpression of 2,3-BD synthesis-related genes in K. pneumoniae. Fed-batch fermentation with a recombinant strain was conducted in a 3 L bioreactor at low pH and resulted in high 2,3-BD productivity.
MATERIALS AND METHODS

Bacterial Strains and Plasmids
The genes encoding acetolactate decarboxylase (budA), acetolactate synthase (budB), and alcohol dehydrogenase (budC) from the butanoate pathway were derived from K. pneumoniae KCTC2242 from the Korean Collection for Type Culture (Fig. 1 ). E. coli HIT-DH5α (RBC Bioscience Corp, Taiwan) was used to clone these genes. The pUC18 plasmid (Takara Shuzo Co., Ltd., Japan) containing the lacZ promoter was used to clone the budA, budB, and budC genes, and the pET28a plasmid (Takara Shuzo Co., Ltd., Japan) was used to clone the kanamycin resistance gene into the pUC18 vector (Table 1) . When necessary, ampicillin (50 µg/ml) and/or kanamycin (50 µg/ml) were added to the medium as selection agents.
Sequencing and Cloning
The sequence information for the genes encoding acetolactate decarboxylase (budA), acetolactate synthase (budB), and acetoin reductase (budC) in K. pneumoniae KCTC2242 was provided by Macrogen Inc., Seoul, Korea. The PA1 and PA2 primers were used to clone the acetolactate decarboxylase (budA) gene at melting temperature (Tm) of 67. (Table 1) . Within the pUC18K vector, the cloned acetolactate decarboxylase (budA) gene fragment was inserted into the EcoRI and BamHI restriction sites, the cloned acetolactate synthase (budB) gene fragment was inserted into the Genes: budB, acetolactate synthase; budA, acetolactate decarboxylase; and budC, alcohol dehydrogenase. The underlined letters denote the restriction sites.
XbaI and HindIII restriction sites, and the cloned acetoin reductase (budC) gene fragment was inserted into the BamHI and XbaI restriction sites. Plasmids were then transformed using electroporation into competent cells prepared from K. pneumoniae KCTC2242. Electroporation (Gene Pulser; Bio-Rad) was performed at 2.48 kV, 25 µF, and 200 Ω in 0.2-cm-gap cuvettes for 50 µl of cells and 1 µl of DNA.
Flask Cultivations K. pneumoniae KCTC2242 and the recombinant K. pneumoniae strains were maintained on LB agar slants. The slants were incubated at 37 
SDS-PAGE for Bacterial Protein Analysis
The recombinant K. pneumoniae SGJSB04 and wild-type strains grown in LB medium containing ampicillin and kanamycin were harvested by centrifugation at 13,000 rpm for 10 min and then washed with PBS (pH 7.5). We outsourced the SDS-PAGE producer to ProteomeTech Inc. (Seoul, Korea.) To confirm expression of the genes, a one-dimensional SDS-PAGE was performed using a 1:1 mixture of sample and lysis buffer (7 M urea, 2 M thiourea, 4% CHAPS, and 1% DTT, diluted to 101.53 ml with water). The samples were sonicated and incubated with a protease inhibitor. Protein concentrations were determined by Bradford assay, and 20 µl of the sample was loaded onto the gel. Using a mini-PROTEAN 3 cell (BIO-RAD) apparatus, electrophoresis was performed using 10% SDS buffer at 50 V for 30-40 min followed by 120V for 2-3 h. The gel was stained using Coomassie Blue G250.
Batch and Fed-Batch Fermentations K. pneumoniae SGJSB04 overexpressing budA and budB genes inserted in pSB4 was the transformed recombinant of K. pneumoniae KCTC2242. This was used to produce 2,3-BD in both batch and fed-batch fermentation scenarios. As discussed below, this was the optimum recombinant strain observed: other strains did not advance past the shake-flask cultivations, because they produced smaller amounts of 2,3-BD (10.5~16.2 g/l) than K. pneumonia SGJSB04 (21.7 g/l) ( Table 3 In the batch and fed-batch fermentations, the pH was maintained at 5.5 by the addition of 5 N HCl or 5 N NaOH. In constant feed rate fedbatch fermentation, 2 L of glucose solution (400 g/l) was fed into the bioreactor at a rate of 3 ml/min (for 10-15 h trials) or 2 ml/min (15-22 h).
Analysis Methods
The cell optical density (OD) of the culture was assayed with a spectrophotometer (BioSpec-mini, Shimadzu Corp.) at 600 nm at an appropriate dilution and was converted to the dry cell weight (DCW).
The supernatants harvested from the culture medium of 200 ml flask fermentations, and 2 L batch and 3 L fed-batch fermentations were analyzed for 2,3-BD content. The amounts of glucose, 2,3-BD, and other substrates were measured using HPLC (Waters Co., USA) with an RI2414 detector (Waters Co., USA) and the Aminex HPX-87H organic acid column (300 mm × 7.8 mm; Bio-Rad). Sulfuric acid (0.01 M) was used as the mobile phase at 60 o C at a flow rate of 0.6 ml/min. All solutions were filtered with a 0.2 µm membrane before use.
RESULTS AND DISCUSSION
Development and Selection of Recombinant K. pneumoniae
The pathway for the biosynthesis of 2,3-BD from glucose is shown in Fig. 1 . The budA, budB, and budC genes code for acetolactate decarboxylase, acetolactate synthase, and alcohol dehydrogenase, respectively. We hypothesized that overexpression of genes responsible for the conversion of glucose to 2,3-BD could result in increased production of 2,3-BD by increasing the production of intermediates. These genes were therefore cloned and characterized in K. pneumoniae in this study. Seven recombinant plasmids were produced, containing one or more of the genes (budA, budB, and budC) ( Table 1) . Each plasmid was transformed by electroporation into competent cells of K. pneumoniae KCTC2242. After the transformants were selected on LB agar medium containing ampicillin and kanamycin, gene expression was confirmed by electrophoresis. The recombinant strains were named K. pneumoniae SGJSB01 (containing pSB1), K. pneumoniae SGJSB02 (containing pSB2), K. pneumoniae SGJSB03 (containing pSB3), K. pneumoniae SGJSB04 (containing pSB4), K. pneumoniae SGJSB05 (containing pSB5), K. pneumoniae SGJSB06 (containing pSB6), and K. pneumoniae SGJSB07 (containing pSB7).
Selection of Recombinant Strains Through Shake-Flask Cultivation
The flask fermentations for all recombinant and wild-type strains of K. pneumoniae were maintained at 37 o C at 200 rpm with a glucose concentration of 60 g/l. The recombinant K. pneumoniae strains indeed displayed a higher 2,3-BD yield than the wild-type strain (Table 3) . Compared with the 2,3-BD production of 13.5 g/l displayed by wild-type K. pneumoniae KCTC2242, K. pneumoniae harboring pSB4 had a maximal production of 21.7 g/l 2,3-BD and a yield of 0.36 g of product per gram of glucose. This is approximately 80% higher than that of the K. pneumoniae control strain (Table 3, Fig. 2 ). The yield of 0.36 g of product per gram of glucose compares favorably with previous 2,3-BD yields observed in other studies (0.12-0.49 g of product/g of glucose) [12] .
The K. pneumoniae SGJSB04 recombinant strain showed smaller amounts of lactate production than wild-type K. pneumoniae (Fig. 2) . Lactic acid may lower the availability of acetoin for 2,3-BD production by competing for NADH [3] . When budA and budB were overexpressed in the recombinant strains, less lactate was produced and elevated acetoin production along with high NADH consumption was observed, resulting in the promotion of 2,3-BD production. Therefore, increased 2,3-BD production correlated with NAD/NADH conversion and the reduction of organic acids that consume NADH. We showed that 2,3-BD production was increased using the engineered K. pneumoniae by overexpressing the budA and the budB.
The production of 2,3-BD by recombinant K. pneumoniae SGJSB07 (budA, budB, and budC genes) was similar to that of wild-type K. pneumoniae (Table 3) . Because acetoin reductase (budC) catalyzes possibly a reversible reaction between acetoin and 2,3-BD [1, 3] , the overexpression of acetoin reductase (budC) is therefore not effective to increase the conversion ratio of acetoin to 2,3-BD. We thereby determined that K. pneumoniae SGJSB04 was the best strain for 2,3-BD production and confirmed this using SDS-PAGE and batch fermentation.
Confirmation of Gene Expression in pSB04 by SDS-PAGE
The K. pneumoniae SGJSB04 strain was created by pSB4 transformation. The expressions of budA and budB in the recombinant cells were confirmed by SDS-PAGE, as shown in Fig. 3 . To induce a strong expression from the plasmid, 1 mM IPTG was added to the LB medium. The wild type with IPTG addition was also cultured as a control. Using the NCBI K. pneumoniae protein database, the molecular masses of the protein products of budA and budB were estimated to be 29 kDa and 60 kDa, respectively. Protein bands corresponding to budA and budB were observed in all samples obtained from the cultures, with IPTG addition (Fig. 3) . Compared with the wild-type sample, budA and budB were expressed at higher levels in the recombinant sample. These results confirmed that the budA and budB genes in pSB4 were overexpressed in K. pneumoniae KCTC2242. 
Batch and Fed-Batch Fermentations
In the batch fermentation, we achieved a 2,3-BD production of 25.52 g/l after 48 h, with a productivity of 0.52 g/l.h and reduced lactic acid production, using the K. pneumoniae SGJSB04 strain (Fig. 4) . This result was higher than achieved with the wild-type K. pneumoniae KCTC22242 strain but lower than reported in previous studies (Table 2) .
Because the purpose of this batch fermentation was to compare 2,3-BD production between the wild-type and optimum recombinant strains under similar conditions to the preceding experiments, but preceding the fed-batch fermentations more relevant to industrial applications, we used only 60 g/l of glucose, not the maximum concentration of glucose for a reactor [5, 7, 13] .
In the fed-batch fermentation, we achieved a 2,3-BD production of 101.53 g/l after 40 h, with a productivity of 2.54 g/l.h and a specific 2,3-BD production of 25.2 g/g dry cell weight (DCW), by feeding glucose solution from the 10 h to the 22 h (Fig. 5) . Additionally, the initial glucose concentration was 100 g/l, a higher concentration than that used in the batch fermentation. Increasing the initial glucose concentration to 100 g/l enhanced the efficiency of bioconversion for 2,3-BD production [14] . In the end, 300 g/l of glucose was consumed during the 40 h monitored and was converted into 101.53 g/l 2,3-BD in the reactor.
When comparing the 2,3-BD production with that of previous studies using fed-batch fermentation, K. pneumoniae SGJSB04 produced relatively high levels of 2,3-BD compared with the other Klebsiella recombinant strains ( Table 2) . Up until now, the maximum reported 2,3-BD production of 150 g/l with a productivity of 4.21 g/l.h in K. pneumoniae was achieved using the constant glucose concentration fed-batch method [7] . This method is similar, but different by the feeding rate we used and utilized a DCW about 10 times higher than ours. Therefore, when taking DCW into consideration, specific 2,3-BD productivity was higher in our study and showed potential for greater productivity.
In conclusion, this study achieved high specific 2,3-BD production in fed-batch fermentation and showed the combinatorial effect of 2,3-BD synthesis-related genes in K. pneumoniae. We characterized and cloned the budA and budB genes and inserted them into wild-type Klebsiella to create a recombinant strain capable of enhanced 2,3-BD biosynthesis. The production of 2,3-BD by K. pneumoniae via fermentation was increased to a greater extent than had been reported in previous studies. The greatest strength of this study is its demonstration that the overexpression of those endogenous genes encoding proteins involved in 2,3-BD biosynthesis results in increased production of 2,3-BD from glucose. These results suggest that recombinant bacterial strains may be used as a strategy to improve the industrial production of 2,3-BD derivatives.
